GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

Good news for people with diabetes who can enjoy better kidney health as well as ward off gout, thanks to a pioneering diabetes drug that can also cut the risk of kidney stones.A study published in ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

(NewMediaWire) - November 11, 2024 - DALLAS GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...

Drugs that belong to the class of GLP-1 receptor agonists could cause muscle loss ... and slow down digestion. These drugs ...

At dinner with my closest friend, conversation turns to weight-loss jabs, and quickly it becomes clear how strongly she ...

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

Use of these drugs can improve diabetes management without increasing risk for hypoglycemia (hypoglycemia is not strictly ...